Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells. (4th November 2015)

• Record Type: Journal Article
• Authors: Ruella, Marco; Barrett, David M; Kenderian, Saad S; Shestova, Olga; Hofmann, Ted J; Scholler, John; Lacey, Simon F; Melenhorst, Jan J; Nazimuddin, Farzana; Perazzelli, Jessica; Christian, David A; Hunter, Christopher A; Porter, David L; June, Carl H; Grupp, Stephan A; Gill, Saar
• Is Part Of: Journal for immunotherapy of cancer. Volume 3(2015)Supplement 2
• Publication Date: 2015-11-04
• Subjects: Acute Myeloid Leukemia -- Chimeric Antigen Receptor -- Leukemia Stem Cell -- CART123 Cell -- CART19 Treatment; Cancer -- Immunotherapy -- Periodicals; Cancer -- Immunological aspects -- Periodicals; Tumors -- Immunological aspects -- Periodicals; Immunotherapy -- Periodicals; 616.99406105
• DOI: 10.1186/2051-1426-3-S2-O5
• Languages: English
• ISSNs: 2051-1426